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Identity 
Other names: Paired box homeotic gene 2 
HGNC (Hugo): PAX2 
Location: 10q24 
 




12 exons, including alternative spliced exons 6 and 10. 
Transcription 










PAX2 is expressed in the developing eye, ear,  
central nervous system (CNS), spinal cord, pancreas  
and urogenital tract. PAX2 contains a DNA binding 
paired domain, a truncated homeodomain, an 





PAX2 is a transcription factor that acts to regulate the 
expression of genes involved in mediating cell 
proliferation and growth, resistance to apoptosis, and 
cell migration. PAX2 null mutant mice die perinatally 
with absent cochlea, kidneys, ureters, oviducts, vas 
deferens and epididymis, also demonstrating mid- and 
hindbrain deficiency and defective optic nerve. 
Homology 
PAX2 shares homology through the conserved paired 
box domain with the other members of the nine strong 
PAX gene family. 
Mutations 
Germinal 
A number of PAX2 mutations have been reported as 
associated with Renal Coloboma Syndrome (see 
below), oligomeganephronia and isolated renal 
hypoplasia. These are collated on the Human PAX2 
















Renal Coloboma Syndrome (RCS) 
Note 
Caused by heterozygous PAX2 mutations. Increased 
apoptosis arising as a result of impaired PAX2 function 
believed to be responsible for disrupted nephron 
formation and arrested cochlear outgrowth. 
Prognosis 
Renal Coloboma Syndrome is associated with end-
stage renal failure and blindness. 
Various cancers, including carcinomas 
of the kidney, carcinomas of the 
prostate, carcinomas of the breast and 
carcinomas of the ovary. Also Wilms’ 
tumour and Kaposi’s sarcoma. 
Disease 
PAX2 is overexpressed in a variety of cancers (see 
below). A detailed understanding of the mechanistic 
contribution mediated by PAX2 has yet to be 
established. However, inhibition of PAX2 expression in 
a number of cancer cell lines induces cell death, 
indicating a role for PAX2 in tumour cell survival. 
Prognosis 
PAX2 is not expressed in normal prostate tissue or 
benign prostatic hyperplasia, but is expressed in 
primary prostatic carcinomas suggesting that PAX2 
expression may be a useful marker of prostate cancer. 
PAX2 expression correlates with proliferation index in 
the majority of kidney tumour subtypes, and expression 
levels are significantly higher in patients presenting 
metastatic disease. PAX2 may therefore provide a 
useful prognostic marker for determining the severity 
of kidney cancers. 
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